← brief for 2026-10-15 · Slowing decline

Utilities of Sodium-Glucose Cotransporter-2 Inhibitor in the Intensive Care Units.

Paper No results yet Peer reviewed

Key takeaways

This review discusses using SGLT2 inhibitors in the ICU. It looks at safety and benefits for critically ill patients. It summarizes current evidence but does not report new trial results.

Who did this work

Cui J · Kashani K

Source

Paper · PubMed, the drug frontier · 2026 Oct 15
https://pubmed.ncbi.nlm.nih.gov/42879328/